James B. Breitmeyer, M.D., Ph.D.
Board Member
Vaxart, Inc. (VXRT)Personal wealth note: Equibles reports source-backed professional activity and disclosed compensation; it does not estimate personal net worth.
About James B. Breitmeyer, M.D., Ph.D.
James B. Breitmeyer, M.D., Ph.D. is recorded as Board Member at Vaxart, Inc. (VXRT). Vaxart, Inc. reported in an 8-K filed April 23, 2026 that James B. Breitmeyer, M.D., Ph.D. was appointed member of the Board, effective April 23, 2026.
“On April 23, 2026, following a recommendation by the Nominating and Governance Committee of the Board of Directors (the “Board”) of Vaxart, Inc. (the “Company”), the Board appointed James B. Breitmeyer, M.D., Ph.D. to serve on the Board, effective immediately, and until Dr. Breitmeyer’s successor is elected and qualified, or sooner in the event of his death, resignation, or removal.”
Summary generated from SEC filings and earnings-call records held by Equibles.
Affiliation history
Recorded current and former roles; source labels appear when available.
-
Current
2026-04-23–present
Company network
Recorded roles and call appearances connecting this person to public companies.
Leadership on record at Vaxart, Inc.
Other people whose current roles at this company are on record from its filings.
- Andrei Floroiu CEO
- Michael Finney CEO
- Michael J. Finney CEO, Board Member
- Steven Lo CEO, Board Member
- Fuad Ahmad CFO
- Phillip E. Lee CFO, Chief Accounting Officer
- Edward Berg General Counsel
- Jeroen Grasman Chief Accounting Officer
- David Wheadon Board Member
- David Wheadon, M.D. Board Member
Recent activity
Earnings-call and investor-event appearances, plus filed executive appointments or departures, newest first.